Related Experiment Video
Updated: Aug 12, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Nephropathia epidemica (hemorrhagic fever with renal syndrome) in Scandinavia
1Department of Infectious Diseases, University of Umeå, Sweden.
Abstract:
Nephropathia epidemica (NE) in Scandinavia is a zoonosis caused by Puumala virus. The main animal reservoir is the bank vole. NE predominantly affects men. Its annual incidence varies in a cyclic fashion, with peaks occurring every third to fourth year. The clinical picture of NE in Scandinavia is similar to that of hemorrhagic fever with renal syndrome in other parts of the world, although NE generally has a milder course. The case-fatality rate is approximately 0.2%. The most common clinical findings in NE are an acute onset of symptoms, fever (greater than or equal to 38 degrees C), oliguria, headache, back pain, and polyuria. Hemorrhagic manifestations are seen in about one-third of cases, and up to 5% of patients have gastrointestinal bleeding or disseminated intravascular coagulation. Thrombocytopenia occurs in a majority of patients. In the acute phase, the glomerular filtration rate is markedly decreased and tubular dysfunction is evident. Most patients with NE recover within 6 months.
Insights
Nephropathia epidemica (NE), a Puumala virus zoonosis primarily affecting men in Scandinavia, presents with flu-like symptoms and kidney dysfunction. Most patients recover within six months, with a low fatality rate.
Area of Science:
- * Infectious Diseases
- * Nephrology
- * Zoonotic Diseases
Background:
- * Nephropathia epidemica (NE) is a zoonotic disease prevalent in Scandinavia.
- * It is caused by the Puumala virus, with the bank vole as its primary animal reservoir.
- * NE typically affects men and exhibits cyclical incidence patterns.
Purpose of the Study:
- * To describe the epidemiology and clinical presentation of Nephropathia epidemica in Scandinavia.
- * To outline the typical course and outcomes of NE in affected individuals.
Main Methods:
- * Review of clinical data and epidemiological patterns of NE in the Scandinavian region.
- * Analysis of common symptoms, laboratory findings, and patient recovery timelines.
Main Results:
- * NE presents with acute symptoms including fever, headache, back pain, and renal impairment (oliguria/polyuria).
- * Hemorrhagic manifestations occur in about one-third of cases; severe complications like DIC are rare (up to 5%).
- * Thrombocytopenia is common, and renal function is significantly impaired during the acute phase.
Conclusions:
- * Nephropathia epidemica in Scandinavia, while similar to other hemorrhagic fever with renal syndrome forms, generally follows a milder clinical course.
- * The disease has a low case-fatality rate (approx. 0.2%) and most patients achieve recovery within six months.
- * Understanding NE's clinical spectrum is crucial for timely diagnosis and management in endemic areas.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Nephrotic Syndrome II : Assessment and Medical Management
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Rocky Mountain Spotted Fever
Diabetic Nephropathy

